Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Public Health Theses

School of Public Health

1-1-2019

The Potential Of Next Generation Whole Genome Sequencing
Using Dogs As A Model To Understand Human Diseases
Emily Xie
emilycxie@gmail.com

Follow this and additional works at: https://elischolar.library.yale.edu/ysphtdl

Recommended Citation
Xie, Emily, "The Potential Of Next Generation Whole Genome Sequencing Using Dogs As A Model To
Understand Human Diseases" (2019). Public Health Theses. 1851.
https://elischolar.library.yale.edu/ysphtdl/1851

This Open Access Thesis is brought to you for free and open access by the School of Public Health at EliScholar –
A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Public Health Theses by an
authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information,
please contact elischolar@yale.edu.

The Potential of Next Generation Whole Genome Sequencing Using Dogs as a Model to
Understand Human Diseases

By
Emily Xie
Year of Completion: 2019
In Candidacy for the Degree of
Master of Public Health
2019

A Thesis Presented to
The Faculty of the Yale School of Public Health
Department: Chronic Disease Epidemiology
Committee Chair: Josephine Hoh, PhD
Committee Member: Andrew Dewan, PhD

Abstract
Background: There has been extensive research in the study of the dog genome and comparative
genomics to human diseases. Dogs were proposed as a candidate primarily because of the
relatively low variation within breeds but high variation between breeds. In this study, we used a
conserved gene among dogs, SMN, to understand the genetic variability across dog breeds and to
compare with human SMN1.
Methods: Using a sequential method design, new dog samples are added into the database as
they become available. This paper is an application of the newly developed algorithms in
studying the similarities and differences in genes between dogs and humans.
Results: In our analysis, we isolated the sequence for SMN across three dogs (two English
Bulldogs and one French Mastiff) and compared the sequence to the reference dog SMN
sequence. We identified a number of SNPs but the differences were located in the intron region
suggesting that potential difference in the exon regions may exhibit deleterious effects in the
animal. The total genetic variation we observed in our three dog samples is less than 1%. When
comparing the reference dog SMN to human SMN1, we observed conserved sequences
predominantly within the exon region of SMN1. The conserved sequences located in the intron
region between SMN1 and dog SMN may suggest that those regions may serve a regulatory
function in gene expression.
Conclusion: There were no meaningful genetic variation within the exon region among our dog
samples for SMN. As additional dog sequences from different breeds are acquired, the
comparison of SMN will be conducted to better understand the genetic variation of the conserved
gene.
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Introduction
In leveraging the application of NGS technology, the genome of Canis lupus familiaris or
dogs was selected as a model for studying human conditions. Dogs have been proposed as a
potential candidate for comparative gene mapping and disease identification among humans
(Deschenes et al. 1994; Parker et al. 2010). There has been extensive research in the study of the
dog genome and comparative genomics to human diseases by Elaine Ostrander and her team in
the past two decades. Ostrander proposes that dogs serve as an excellent model for investigating
complex human diseases. Firstly, dogs and humans share similar health diseases that may be
caused by similar genes between the two species such as cancer and autoimmune diseases (Sutter
and Ostrander et al. 2004; Parker et al. 2010). Secondly, the unique breeding patterns for dogs
have led to a relatively phenotypic homogeneous population thereby reducing genetic diversity
within breeds (Ostrander et al. 2010). Lastly, dogs and humans share similar environmental
exposures and so the history of disease onset and progression may be similar between these two
species (Shearin et al. 2010).
The dog genome contains approximately 3 billion base pairs and 39 pairs of
chromosomes (NHGRI 2018). It is estimated that about 25% of the dog sequence aligns to the
human genome (Kirkness et al. 2003) making the dog an attractive model for comparative
analysis in understanding the genetic basis of diseases between dogs and humans. In this project,
the Illumina NGS technology will be used to sequence the genome of the English Bulldog and
French Mastiff with 30-times read coverage. Not only has this technique never been applied in
this form of research and it will expand upon existing knowledge about the dog genome, and will
be used as a comparison to the existing reference genome. Compared to other NGS technologies
(SOLiD system, Roche 454 system, and Illumina HiSeq system), Illumina’s HiSeq system
generates the greatest sequencing output at the lowest operating cost (Liu et al. 2012).
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Through employing the Illumina sequencing system to generate reads for the dog
genome, we will investigate a highly conserved gene across dog breeds, comparing it with the
human gene equivalent. The study of comparative genomics is a growing field and with
advancing technology, there is a need for new algorithms to handle large datasets. Comparing the
conserved genes across species to identify regions of similarity and difference may allow
researchers to better understand the structure and function of human genes, health conditions,
and ultimately improve treatment options. Identifying DNA sequences that have been preserved
in different dog breeds and in humans may contribute to the development of innovative
treatments for complex human diseases that would enhance health.
The conserved gene of interest within the dog genome in this study is SMN. SMN or
survival motor neuron is a gene associated with the human condition, spinal muscular atrophy or
SMA (Nizzardo et al. 2015). Humans have two copies of the gene, SMN1 and SMN2, both of
which express the survival motor neuron (SMN) protein. This protein is highly expressed in the
spinal cord and is critical for the function of motor neurons. By studying the gene in another
species, we may decode the mystery and understand the structure and function of the conserved
gene. This knowledge may be valuable in developing newer therapies in addressing the medical
needs for patients with SMA.

Methods
Using a sequential method design, new samples are added into the database as they become
available. This paper is an application of the newly developed algorithms in studying the
similarities and differences in genes between dogs and humans. The overall aim of the project is
to study the genetic variation among conserved genes in dogs and to understand the function it
may serve in order to investigate human diseases. In this study, we will be studying a highly
conserved gene, SMN, to study the genetic variability across dog breeds and to compare the gene
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with the human equivalent. Refer to Table 1 for characteristics of the dogs. There are three subaims
1. In a sequential manner, collect and prepare blood sample from dogs for Next Generation
Whole Genome Sequencing.
2. Utilize Illumina platform to perform WGS technology to sequence the samples.
3. Apply the analysis of SMN and identify conserved regions, biological relevant SNPs and
indels within promoter and/or exon regions if applicable.
The analysis is conducted on the initial three dog samples acquired.
DNA Extraction
Blood samples were purified and extracted using the QIAamp Blood Midi Kit (Spin Protocol).
Two milliliters of whole blood were collected per tube and 1x PBS was used to bring the volume
of the sample up to 2 ml if necessary before proceeding to purify and extract genomic DNA.
Purified and extracted DNA samples were stored at -20°C. The concentration of the purified
DNA was determined via the Nanodrop spectrophotometer and by PicoGreen Assay before
library preparation. These samples were then sent to Yale Center for Genome Analysis (YCGA)
for Next Generation DNA sequencing.
NanoDrop DNA Quantification
Table 3 provides the recorded concentration for five representative dog samples via the
NanoDrop. The three dog samples (1Y, 2O, and MW) used for analysis was not incorporated in
the table.
The Nanodrop spectrophotometer is a common lab instrument used to measure the concentration
of DNA and the A260/280 ratio indicates potential sources of contamination among the samples.
Blood samples from five dogs were extracted and purified. Depending on the amount of blood
available for extraction, some samples were divided into two or four vials. As we do not have

5

control over the amount of leftover blood for collection, we maximized the amount of genomic
DNA extracted when possible. Samples 1 and 2 were divided into four vials for DNA extraction
and purification. Sample 3,4 and 5 were divided into two vials for DNA extraction and
purification.
PicoGreen Assay
Table 4 provides the recorded concentration for five representative dog samples via the
PicoGreen Assay. The three dog samples (1Y, 2O, and MW) used for analysis was not
incorporated in the table.
The Pico Green DNA quantification assay is a sensitive method to detect small amounts of
double stranded DNA in samples through a DNA binding fluorescent dye. The assay reports an
exact concentration of the purified genomic DNA samples.
Whole Genome Sequencing by NGS technology
2ug of genomic DNA as measured by the PicoGreen assay was required for the PCR-FREE
library prep approach. Sequencing was run on the Illumina NovaSeq 6000 and 30X depth. The
Illumina platform used bridge amplification for sequencing by synthesis. Paired end reads were
generated to maximize coverage and confidence in determining sequence.
Alignment and Extraction of aligned reads
The Burrow-Wheeler Aligner (BWA) software package was used for mapping sequences to a
reference genome (CANFAM3.1) (Heng et al. 2009). The BWA-MEM algorithm was used and
alignments were outputted in the SAM format and converted to the BAM output file for analysis
BWA-MEM is an alignment algorithm that performs mapping of paired-end reads to a reference
genome (Heng et al. 2013). Tolerance for sequencing errors is 3% error using the BWA-MEM
algorithm for 200bp. Reads are 151bp long (Heng et al. 2009). The alignment file is outputted in
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the standard SAM format. The Samtools software package via the Samtools view command line
was used to extract reads for regions that covered the SMN and outputted in a text file.
Analysis Programs Developed By Yitao Yan, Hang Li, and Josephine Hoh
The software was written by computational scientists from Dr. Josephine Hoh’s lab and is still
currently being revised for improvement. The initial program assesses all of the reads for each
position and summarizes the sequence with the majority of reads in agreement with each other
and highlights any mismatches. The output file contains information of the general sequence for
the gene after consolidating information about all the reads for each position to propose a
potential single consensus sequence for the sample. The major limitation in this program is that it
is not sensitive to indels, gaps, and does not take into consideration the quality score of the reads.
Therefore, the accuracy of the consensus sequence may be reduced.
The follow up program takes the output from Program 1 and conducts a comparison of the
sequence file for each sample. This comparison is conducted between the publicly available
reference dog sequence (CANFAM3.1) and our sequenced samples. Here, all proposed majority
sequences for the gene were compared among all samples and to the reference. The summary
output describes any mismatches in the majority sequence between each sample and to the
reference sequence.
Annotation of the Gene
Annotation for SMN was extracted from NCBI and used for annotating the gene through the
Integrated Genome Browser software. The annotation is based on the publicly available
reference genome of the Boxer (CANFAM3.1). This is essentially a “copy and paste”
mechanism leveraging the position of the nucleotides which is compared to the reference dog
genome.
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Results
DNA Quantification as a Measure for Quality:
The Nanodrop spectrophotometer is a common lab instrument used to measure the concentration
of DNA and the A260/280 ratio indicates potential sources of contamination among the samples.
Among the five dog samples, the mean DNA concentration ranged from 41.2 ng/ul to 50.5 ng/ul.
The A260/280 ratio is used to determine the presence of protein contamination in the sample.
Pure DNA samples should have a ratio of 1.8 and a lower value suggests potential contamination
which may impact downstream application of the DNA for sequencing. Overall, the ratio for all
of the purified DNA samples ranged between 1.66 to 1.83. Two samples (2d and 6b) suggested
potential protein contamination and were excluded for WGS sequencing.
The following measures were obtained via the PicoGreen assay. The range of the concentrations
for the five samples were between 25.2 ng/ul to 50.7 ng/ul (Table 4). When compared to the
NanoDrop measurements, the Pico Green reported concentrations at a lower value suggesting
that the NanoDrop overestimates the actual DNA concentration of the extracted samples. It is
essential that the quantity and concentration of DNA is sufficient for WGS.
Data Quality of the Assembly
The highly conserved SMN gene was used as an example for conducting the comparative
analysis across dog samples. Read depth was used as a rough measure of the quality for the
assembly. Using NGS, the whole genome of the dog samples was sequenced with 30X coverage
and reads of length 151bp. The average read depth across dog SMN for samples 1Y, 2O, and
MW are 24.6 ±6.76, 17.35±5.30, and 37.12±9.86 respectively (Figures 1-3)
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Genetic Variation among the three Dog samples in relation to the Reference Gene.
The SMN region for each of the three samples were extracted and the overall majority
sequence for the SMN gene was generated. The majority sequence for a position was determined
by calculating the number of bases for each position. The position with the greatest number of
consenting reads was the proposed majority sequence for the position. The majority sequence for
the three samples were compared with the reference SMN sequence.
Based on the pairwise comparison of the majority sequence between each of the samples
to the reference SMN sequence, there were no genetic variations identified within the exon
regions. All of the genetic differences were identified in the intron region. When conducting a
pairwise comparison of the gene between the three samples and the reference sequence, MW had
the most genetic differences than 1Y or 2O. This is expected as 1Y and 2O are English Bulldogs
and is hypothesized to have similar genetic patterns within the gene. MW is a French Mastiff and
contains the most genetic variation within SMN when compared to the reference which is a
boxer. The total genetic variation in 1Y, 2O, and MW are 0.12%, 0.10%, and 0.58%
respectively.
Comparison of Reference Dog SMN to human SMN1
Currently we are still developing an algorithm to compare the dog SMN to human SMN1 and
SMN2. Publicly available programs such as UCSC blat tools were used to conduct the
comparative analysis between dogs and humans. The reference dog SMN gene was extracted and
compared to the human SMN1 gene via USCS blat software. SMN1 is located on Chr5:
70,925,030-70,953,012 (27,983 bp) and the dog SMN is located on Chr2: 54,596,006-54,636,762
(40,757 bp). The overall genetic similarity between dog SMN and human SMN1 is 89.5%,
mapping to about 7,413 base pairs in human SMN1. There appears to be conserved regions
across exons 2 to 7 between human SMN1 and dog SMN. This suggests that these conserved
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regions may serve an important function in survival among dogs and humans. Among intron 2, 4,
and 5 in human SMN1 there are conserved sequences between dogs and humans suggesting
potential regulatory functions within those regions.

Discussion
The overarching goal of the project on a large scale is to utilize the dog genome as a
surrogate to study what is unknown in gene variability in relation to function and diseases in
understanding human conditions. Dogs were proposed as a candidate primarily because of the
relatively low variation within breeds but high variation between breeds. The project is
hypothesis-free, and data are generated in a sequential manner as additional dog samples are
acquired and added into the growing genome database. In this project, we used a conserved gene
among dogs, SMN, to understand the genetic variability across dog breeds and to compare with
human SMN1.
In our study, we aimed to compare a highly conserved gene across dog breeds to identify
potential genetic variations that may have biological implications for the progression of SMA. In
our analysis, we isolated the sequence for the gene across three dogs and compared the sequence
to the reference dog sequence. We identified a number of SNPs but the differences were located
in the intron region suggesting that potential difference in the exon regions may exhibit
deleterious effects in the animal. As additional dog sequences from different breeds are acquired,
the comparison of SMN will be conducted to better understand the genetic variation of the
conserved gene. Literature suggests that the clinical progression of hereditary canine spinal
atrophy is phenotypically similar to human SMA, but the condition is not associated with dog
SMN (Blazej et al. 1998). Although SMN in dogs may not be associated with HCSMA, the gene
may play a critical role in survival as it is highly conserved across the three dog samples.
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The major limitation in the study is that the programs used to generate the majority
sequence across the gene has flaws. The program does not consider the quality of the reads
generated by the NGS system. The quality of the sequence is reported as a character that
corresponds to the level of confidence in calling the sequence for the region. Therefore, the
major limitation of this analysis is the lack of quality control measures to assess the accuracy or
precision of the majority sequence that is generated by the program. The reported sequence may
not be accurate with high certainty. Further research is recommended to develop robust
algorithms and software programs to process the sequencing data generated by NGS for
comparative analysis of dog and human genome. Lastly, future approaches in the project will
include sequencing more dogs across different breeds to build an extensive dog genome
database. Other potential genes associated with canine and human cancers will be analyzed to
explore the genetic variation across dog breeds.
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Table 1: Dogs in the dissertation study (first three samples in the
sequential collection)

12

Table 2: NanoDrop measurements of sample genomic DNA: Five
representative dog samples were extracted and purified. Samples 1Y, 2O, and MW were not
incorporated in the table. The amount of blood acquired varied and were divided into two or four
vials depending on the quantity of blood available. The five samples are numbered (1-5) and
divided into vials labeled (a-d) if applicable. Columns 1 and 2 refers to the ID for each tube.
Column 3 represents the concentration of DNA measured. Columns 4 and 5 refer to the 260/280
and 260/230 ratios respectively for each sample tube. Columns 6-9 represent the average DNA
concentration, standard deviation, minimum concentration, and maximum concentration for each
sample (1-5).
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Table 3: Qubit Fluorometer Measurements of Sample genomic DNA: The
DNA concentration of the five representative dog samples were quantified via the Qubit
Fluorometer. Samples 1Y, 2O, and MW were not incorporated in the table. Columns 1 and 2
refer to the identification coding for the tube and corresponds to the ID coding used for the
NanoDrop measurements. Column 3 refers to the reported DNA concentration. Columns 4-5
refers to the quantity of DNA obtained and the corresponding net DNA concentration yield.

Sample

Code on tube

Qubit (ng/ul)

Volume (ul)

Yield (ng)

1a+1b

Anna-CH-1-DW

30.1

150

4515

2a+2b

Scotia-GL-1-DW

50.7

150

7605

3a

Chevy-GL-CL

25.2

150

3780

4a

RB-DW-110718

45.2

300

13560

5a

GS-PO-DS111-WU

49.2

150

7380
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Table 4: Output for majority consensus sequence for each position
across the SMN gene for the individual sample. This is a pairwise comparison
between the sample SMN sequence and the reference dog SMN sequence. Column 1 refers to the
overall consensus sequence and is determined based on the majority sequence for the position.
Column 2 refers to the position of the sequence relative to the reference dog sequence. Column 3
provides the total number of reads identified within each position. Column 4 outputs the different
base pairs relative to the reference sequence for that position. Column 5 refers to the number of
different base pairs for the position.

Program 1: Output for Sample 1
• Compares each sample to reference individually, output is text file
Overall consensus sequence Position rel. to Ref

# reads

Diff BP

# Diff BP

***Programs 1 and 2 were developed by Yitao and Josephine***
***Heng is currently revising programs 1 and 2 ***
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Table 5: Output of analysis program that compares the overall majority
sequence for each sample to the reference SMN sequence. Any differences
in base pairs are denoted by a star. The differences are potential genetic variants or SNPs within
the SMN gene across the three samples and the dog reference sequence. Column 1 refers to the
position of the sequence across the SMN gene. Column 2 provides the reference dog sequence for
the position. Columns 3-5 provides the overall majority sequence for samples 1Y, 2O, and MW
respectively. Column 6 may provide a star to indicate potential SNPs at the position.

Program 2
• Compares all the samples to each other and to the reference
sequence, output is text file.
Position

Reference

1Y

2O

MW

Denotes a difference
in base pair to
reference

***Programs 1 and 2 were developed by Yitao and Josephine***
***Heng is currently revising programs 1 and 2 ***
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Table 6: Total genetic variation across samples 1Y, 2O, and MW for SMN.
The overall majority sequence for each sample is compared to the reference SMN. Reference
SMN is obtained from the publicly available dog genome (CanFam3.1) through the National
Center for Biotechnology Information (NCBI).
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Table 7: Total genetic variation in SMN across 2,000 bp blocks for
samples 1Y, 2O, and MW when compared to the reference SMN. The xaxis refers to the 2,000 base pair block across the SMN gene. The y-axis refers to the total
number of genetic variation within the 2,000 bp region/ total base pairs in the SMN region.
Samples 1Y, 2O, and MW are represented by the blue, red, and gray bars respectively.

Table 8: Total genetic variation across samples 1Y, 2O, and MW for SMN
when compared with the reference SMN. The x-axis refers to the position across
the gene while the y-axis represents the total genetic variation for the position.
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Figures 1a-1c: An example of read depth for Samples 1Y, 2O, and MW
across the dog SMN gene. The x-axis refers to the position within the SMN gene and the
y-axis refers to the number of reads covering the position. Read depth refers to the number of
sequenced reads that aligned to the reference sequence for each region. The average read depth
for sample 1Y was roughly 24-25 reads, for sample 2O was 17-18, and for sample MW was 910. The table below provides details about the total number of reads generated within the SMN
gene for each sample, the average read depth across the gene, the standard deviation of read
depth, and the maximum/minimum reads through the gene.

1a:

Variable |
Obs
Mean Std. Dev.
Min
Max
-------------+--------------------------------------------------------reads | 168,456 24.60
6.76
1
55
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1b:

Variable |
Obs
Mean Std. Dev.
Min
Max
-------------+--------------------------------------------------------reads | 42,121 17.35
5.30
1
38
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1c: Note that MW030918 and MW are equivalent.

Variable |
Obs
Mean Std. Dev.
Min
Max
-------------+--------------------------------------------------------reads | 42,125 37.12
9.86
1
114
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Figure 2: The reference dog SMN sequence was compared with the
human SMN sequence. About 7,413 base pairs aligned with the human SMN sequence on
Chr5. The percentage of similarity between the two is 89.5%.

Comparison of dog SMN to human SMN
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